Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 21,300 | 0 | 0 | 0 | 0 |
| Gross Profit | 21,300 | N/A | N/A | N/A | N/A |
| Operating Expenses | 173,696 | 73,178 | 36,075 | 20,690 | 10,290 |
| Operating Income | -152,396 | -73,178 | -36,075 | -20,690 | -10,290 |
| Other Income | 3,520 | 780 | 199 | 18 | 0 |
| Pre-tax Income | -148,876 | -72,398 | -35,876 | -20,672 | -10,290 |
| Net Income Continuous | -148,876 | -72,398 | -35,876 | -20,672 | -10,290 |
| Net Income | $-148,876 | $-72,398 | $-35,876 | $-20,672 | $-10,290 |
| EPS Basic Total Ops | -5.31 | -3.46 | -2.12 | -3.06 | -70.79 |
| EPS Basic Continuous Ops | -5.31 | -3.46 | -2.12 | -3.05 | -70.48 |
| EPS Diluted Total Ops | -5.31 | -3.46 | -2.12 | -3.06 | -70.79 |
| EPS Diluted Continuous Ops | -5.31 | -3.46 | -2.12 | -3.05 | -70.48 |
| EPS Diluted Before Non-Recurring Items | -5.31 | -3.46 | -2.12 | -3.06 | N/A |
| EBITDA(a) | $-152,191 | $-72,573 | $-35,667 | $-20,660 | $-10,290 |